Novo Nordisk Diabetes Drug Victoza Gets EU Approval - Wall Street Journal
Posted July 4th, 2009Categories: Diabetes Mellitus
Novo Nordisk Diabetes Drug Victoza Gets EU Approval - Wall Street Journal
![]() dBTechno |
Novo Nordisk Diabetes Drug Victoza Gets EU Approval
Wall Street Journal Victoza, also known as Liraglutide, belongs to a relatively new kind of diabetes drug class known as GLP-1 analogues. In contrast to conventional treatment … Novo Nordisk wins Europe OK for diabetes drug EU Approves Novo Nordisk's Drug For Type 2 Diabetes Treatment EU Commission Approves Victoza for Diabetes Patients |
